Feasibility of a Walking Program for Cancer Survivors Receiving Radiation Therapy (PEDWAY)
Feasibility of a Supported Walking Program for Breast and Head-and-Neck Cancer Survivors Receiving Adjuvant Radiation Therapy
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Alberta
-
Edmonton, Alberta, Canada, T6J4P9
- Cross Cancer Institute
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Survivors with a diagnosis of breast cancer or head and neck cancer
- Adults aged 18 years or older
- Commencing adjuvant radiation therapy treatments
- Karnofsky Performance Status greater than or equal to 60%
Exclusion Criteria:
- Clinical or radiological evidence of active disease, either local or metastatic
- Serious non-malignant disease, such as cardiac failure or advanced arthritis of weight bearing joints, which would preclude daily treatment and follow-up
- Patients for whom physical activity or exercise is contraindicated
- Psychiatric or addictive disorders which preclude obtaining informed consent or adherence to the protocol
- Unable to comply with the protocol, measurement and follow-up schedule (e.g., scheduling conflicts, time commitment)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Walking Intervention
Pedometer Walking Program
|
All subjects will be prescribed a low-intensity walking program based on their current activity level and an daily assigned step count goal (with the current physical activity recommendations of 30 minutes of moderate-to-vigorous activity per day or 150 minutes per week as the ideal goal).
Participants will be provided with face-to-face counseling and written material describing their specific individualized walking program.
Participants will also be instructed to maintain their normal activities as much as possible during the intervention period.
Participants will be given a pedometer and instructed to wear it at least 5 days per week for the duration of the study.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Accrual Rate and Completion Rate
Tidsramme: Anticipated duration of radiation therapy of 6 weeks
|
Accrual: Number of participants agreeing to participate divided by the number of eligible participants Completion rate: number of participants completing the trial
|
Anticipated duration of radiation therapy of 6 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Adherence
Tidsramme: Anticipated duration of radiation therapy of 6 weeks
|
Adherence to the intervention protocol: number of days meeting target step count
|
Anticipated duration of radiation therapy of 6 weeks
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
6-Minute Walk Test
Tidsramme: Change from baseline to anticipated end of radiation therapy of 6 weeks
|
The six-minute walk test (6MWT) measures the distance an individual is able to walk over a six minutes time period on a hard, flat surface (e.g., 100 foot hallway).
|
Change from baseline to anticipated end of radiation therapy of 6 weeks
|
|
Physical Activity
Tidsramme: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
An accelerometer armband will be used to provide a breakdown of an individual's daily activity.
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
|
Self-esteem
Tidsramme: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Rosenberg Self-Esteem Scale (10 item)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
|
Depression
Tidsramme: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Beck Depression Inventory II (21 item)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
|
Happiness
Tidsramme: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Oxford Happiness Questionnaire (29 items)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
|
Sleep
Tidsramme: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Pittsburgh Sleep Quality Index (9 item)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
|
Fatigue
Tidsramme: Recorded daily during study period of 6 weeks
|
Visual analogue scale, recorded as part of daily diary
|
Recorded daily during study period of 6 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Margaret McNeely, PhD, University of Alberta and Cross Cancer Institute
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- ACREC 26059
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .